Industry: Pharmaceuticals, Biotechnology
Saegis is a development-stage company focused on the discovery of drugs to address behavioral disorders. Saegis has clinically evaluated three small molecule drugs and has a growing pipeline of novel treatments for central nervous system (CNS) diseases involving cognitive dysfunction. The company’s focus is on Alzheimer’s Disease (AD), Mild Cognitive Impairment (MCI), Cognitive Impairment Associated with Schizophrenia (CIAS), and Attention Deficit Hyperactivity Disorder (ADHD). By developing a new generation of CNS therapeutics, Saegis is committed to giving new hope to patients facing memory loss and cognition deficits associated with aging, psychiatric disorders and brain ( www.saegispharma.com )
Saegis Pharmaceuticals , Inc.
60 Stone Pine Road Suite 200
Half Moon Bay, California 94019
USA
Tel: (650) 560-0210
Fax: (650) 560-0211